Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Proteins|December 18, 2001
Hierarchy of simulation models in predicting molecular recognition mechanisms from the binding energy landscapes: structural analysis of the peptide complexes with SH2 domainsG M Verkhivker, D Bouzida, D K Gehlhaar, et al.Proteins|July 1, 1997
Structural consensus in ligand-protein docking identifies recognition peptide motifs that bind streptavidinN K Shah, P A Rejto, G M VerkhivkerBiochemistry|October 5, 1976
A detailed structural comparison between the charge relay system in chymotrypsinogen and in alpha-chymotrypsinJ J Birktoft, J Kraut, S T FreerProtein Engineering|July 1, 1995
Empirical free energy calculations of ligand-protein crystallographic complexes. I. Knowledge-based ligand-protein interaction potentials applied to the prediction of human immunodeficiency virus 1 protease binding affinityG Verkhivker, K Appelt, S T Freer, et al.The Journal of Biological Chemistry|January 20, 1975
Crystallographic structure refinement of Chromatium high potential iron protein at two Angstroms resolutionS T Freer, R A Alden, C W Carter, et al.The Journal of Biological Chemistry|May 25, 1979
Dihydrofolate reductase from Lactobacillus casei. Stereochemistry of NADPH bindingD A Matthews, R A Alden, S T Freer, et al.The Journal of Biological Chemistry|February 25, 1976
Polypeptide halomethyl ketones bind to serine proteases as analogs of the tetrahedral intermediate. X-ray crystallographic comparison of lysine- and phenylalanine-polypeptide chloromethyl ketone-inhibited subtilisinT L Poulos, R A Alden, S T Freer, et al.The Journal of Biological Chemistry|September 25, 1975
X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition stateD A Matthews, R A Alden, J J Birktoft, et al.Journal of Medicinal Chemistry|February 3, 1995
De novo design of enzyme inhibitors by Monte Carlo ligand generationD K Gehlhaar, K E Moerder, D Zichi, et al.The Journal of Endocrinology|April 25, 2008
A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesisI J Bujalska, L L Gathercole, J W Tomlinson, et al.Pageof 3